MY124599A - Oral suspension of pharmaceutical substance - Google Patents

Oral suspension of pharmaceutical substance

Info

Publication number
MY124599A
MY124599A MYPI99001139A MYPI9901139A MY124599A MY 124599 A MY124599 A MY 124599A MY PI99001139 A MYPI99001139 A MY PI99001139A MY PI9901139 A MYPI9901139 A MY PI9901139A MY 124599 A MY124599 A MY 124599A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical substance
oral suspension
small amounts
stanbilised
meloxim
Prior art date
Application number
MYPI99001139A
Inventor
Dietrich Dr Turck
Veit Dr Schmelmer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MY124599A publication Critical patent/MY124599A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

THE PRESENT INVENTION RELATES TO ORALLY ADMINISTERED SUSPENSIONS OF PHARMACEUTICAL ACTIVE SUBSTANCES OF THE NSAID TYPE, PARTICULARLY THE ANTIRHEUMATIC AGENT MELOXIM, WHICH ARE STANBILISED BY THE ADDITION OF SMALL AMOUNTS OF HIGHLY DISPERSED SILICON DIOXIDE USING HIGH SHEAR FORCES AND ADDING SMALL AMOUNTS OF HYDROPHILIC POLYMERS TO FORM A THREE-DIMENSIONAL SILOID STRUCTURE, AND A PROCESS FOR THE PREPARATION THEREOF.(FIG. 4)
MYPI99001139A 1998-03-27 1999-03-25 Oral suspension of pharmaceutical substance MY124599A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (en) 1998-03-27 1998-03-27 Peroral drug suspension

Publications (1)

Publication Number Publication Date
MY124599A true MY124599A (en) 2006-06-30

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI99001139A MY124599A (en) 1998-03-27 1999-03-25 Oral suspension of pharmaceutical substance

Country Status (26)

Country Link
EP (2) EP0945131A1 (en)
JP (1) JP3323189B2 (en)
KR (1) KR100587208B1 (en)
CN (1) CN1150888C (en)
AR (1) AR016196A1 (en)
AT (1) ATE225648T1 (en)
AU (1) AU762464B2 (en)
BR (1) BR9909189A (en)
CA (1) CA2326048C (en)
CO (1) CO5070601A1 (en)
DE (1) DE59903023D1 (en)
DK (1) DK1066029T3 (en)
ES (1) ES2184428T3 (en)
HK (1) HK1034184A1 (en)
HU (1) HU228474B1 (en)
IL (1) IL137479A (en)
MY (1) MY124599A (en)
NO (1) NO321401B1 (en)
NZ (1) NZ507610A (en)
PL (1) PL192969B1 (en)
PT (1) PT1066029E (en)
TR (1) TR200002772T2 (en)
TW (1) TWI232759B (en)
UY (1) UY25443A1 (en)
WO (1) WO1999049845A1 (en)
ZA (1) ZA200003951B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
US20070042006A1 (en) * 2003-04-07 2007-02-22 Lau Kai K Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
DE602005009016D1 (en) * 2004-12-06 2008-09-25 Janssen Pharmaceutica Nv ORAL SUSPENSION WITH MELOXICAM
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
CA2777366C (en) * 2009-10-12 2023-11-14 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
CA2800235C (en) * 2010-03-10 2018-10-16 Lupin Limited Rifaximin ready-to-use suspension
RU2015142279A (en) * 2010-03-19 2018-12-28 Бостон Байомедикал, Инк. NEW COMPOUNDS AND COMPOSITIONS FOR TARGETING MALIGNANT STEM CELLS
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
CN104854411B (en) * 2012-12-19 2017-06-13 三菱电机株式会社 Air conditioner
RU2749423C2 (en) 2015-04-28 2021-06-10 Марс, Инкорпорейтед Method for producing sterilized wet feed product for pets
KR102145022B1 (en) * 2018-08-14 2020-08-14 동아제약 주식회사 Suspension composition and dosage form of ibuprofen
CN112044605B (en) * 2019-06-06 2022-06-21 钟志勇 Titanium selection medicament and titanium selection method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (en) * 1984-10-22 1988-11-16 Chiesi Farma Spa AQUEOUS PHARMACEUTICAL FORMULATIONS OF PIROXICAM MONOHYDRATE
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (en) * 1992-03-10 1999-02-24 エスエス製薬株式会社 Planoprofen suspension syrup
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
NO20004822L (en) 2000-11-23
EP1066029B1 (en) 2002-10-09
JP3323189B2 (en) 2002-09-09
DK1066029T3 (en) 2003-01-27
KR100587208B1 (en) 2006-06-08
AU3147099A (en) 1999-10-18
JP2002509875A (en) 2002-04-02
CN1295462A (en) 2001-05-16
PL192969B1 (en) 2006-12-29
WO1999049845A1 (en) 1999-10-07
HUP0102036A2 (en) 2002-03-28
TR200002772T2 (en) 2000-12-21
HU228474B1 (en) 2013-03-28
PL342345A1 (en) 2001-06-04
TWI232759B (en) 2005-05-21
NO321401B1 (en) 2006-05-08
ES2184428T3 (en) 2003-04-01
KR20010042197A (en) 2001-05-25
BR9909189A (en) 2000-12-05
HUP0102036A3 (en) 2002-12-28
CA2326048C (en) 2008-08-12
AR016196A1 (en) 2001-06-20
AU762464B2 (en) 2003-06-26
ZA200003951B (en) 2002-01-18
IL137479A0 (en) 2001-07-24
IL137479A (en) 2005-09-25
DE59903023D1 (en) 2002-11-14
NO20004822D0 (en) 2000-09-26
ATE225648T1 (en) 2002-10-15
CO5070601A1 (en) 2001-08-28
HK1034184A1 (en) 2001-10-19
PT1066029E (en) 2003-02-28
CN1150888C (en) 2004-05-26
EP1066029A1 (en) 2001-01-10
CA2326048A1 (en) 1999-10-07
NZ507610A (en) 2003-08-29
EP0945131A1 (en) 1999-09-29
UY25443A1 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
MY124599A (en) Oral suspension of pharmaceutical substance
ATE554750T1 (en) PREPARATIONS CONTAINING HYDROPHOBIC PHARMACEUTICAL ACTIVE INGREDIENTS
HUP0302086A2 (en) Oral pharmaceutical composition with a delayed action and process for its preparation
DE69812343D1 (en) SOLID PHARMACEUTICAL FORMULATIONS CONTAINING A PHYSICAL MIXTURE OF SULPHOALKYLETHERCYCLODEXTRIN AND A THERAPEUTIC ACTIVE SUBSTANCE
TNSN96141A1 (en) PHARMACEUTICAL FORMULATIONS AND PROCESS FOR THEIR PRODUCTION
MA26471A1 (en) ARYLSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MA26571A1 (en) HYDROXAMIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION
BR9814818A (en) Treatment methods of capsules and dry powder pharmaceutical formulations
HUP0101237A1 (en) Sustained release preparations
ATE224717T1 (en) ORAL MEDICINAL PREPARATIONS CONTAINING A BENZHYDRYLPIPERAZINE AND A CYCLODEXTRIN
PT1131050E (en) GALENSE FORMULATIONS WHICH DISINTEGRATE QUICKLY IN THE MOUTH AND METHOD FOR THE PREPARATION
NO20011211D0 (en) Multiple unit for controlled feed effect-independent release of pharmaceutical preparations and methods for the preparation of the same
TNSN03106A1 (en) PROCESS FOR THE PRODUCTION OF A LOW DOSE PHARMACEUTICAL COMPOSITION HAVING A UNIFORM DISTRIBUTION AND DRUG ACTIVITY
HUP0202781A2 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
DK0765157T3 (en) Pellets
DK1104289T3 (en) New oral formulations for 5-HT 4 agonists or antagonists
IL150528A0 (en) Ibuprofen containing active agent preparation
BR9917220A (en) Composition for gum chewing gums, process for producing damesma, and tablets thus obtained
FR2705232B1 (en) Process for the preparation of dry prepared particles, dry prepared particles thus obtained and pharmaceutical compositions containing such particles.
BR0010521A (en) Pharmaceutical compositions for oral administration of floroglucinol and its preparation
GEP20043377B (en) Pharmaceutical Complex
DE60032372D1 (en) MEDICINE PREPARATIONS CONTAINING PACLITAXEL INCLUDED IN NANOPARTICLES OF POLYMERIC MICELLES
DZ3103A1 (en) New substituted pyrazolo Ä4,3-EÜdiazepines, pharmaceutical compositions containing them, use as medicament and processes for their preparation.
TR200003451T2 (en) Pyrimidine-Aminomethyl-Pyridine Derivatives, Their Preparation and Their Use in the Control of Helicobacter Bacteria
HUP0002403A2 (en) Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them